Literature DB >> 26199754

Benzoquinoline amines - Key intermediates for the synthesis of angular and linear dinaphthonaphthyridines.

Kolandaivel Prabha1, K J Rajendra Prasad1.   

Abstract

A systematic study on the condensation reaction of 2,4-dichlorobenzo[h]quinoline and naphth-1-ylamine in the presence of CuI as catalyst to functionalised mono- and di-substituted (naphthalen-1-yl)benzo[h]quinoline amines was described. Subsequently these mono- and di-substituted amines on polyphosphoric acid catalysed cyclisation reaction with aromatic/heteroaromatic carboxylic acids led to the construction of angular and linear aromatic/heteroaromatic substituted dinaphthonaphthyridines in good yields.

Entities:  

Keywords:  2,4-Dichlorobenzo[h]quinoline; CuI catalyst; Dinaphthonaphthyridines; Naphth-1-ylamine

Year:  2014        PMID: 26199754      PMCID: PMC4506974          DOI: 10.1016/j.jare.2014.02.007

Source DB:  PubMed          Journal:  J Adv Res        ISSN: 2090-1224            Impact factor:   10.479


Introduction

In a quest to obtain lead molecules in the medicinal chemistry, small molecules appended with differently substituted functional groups can be of great interest, due to their potential to create a number of chemical libraries. Among those, nitrogen containing heterocycles such as quinolines and naphthyridines draw special attention due to their wide variety of biological activities. For instance, quinoline based chemical entities were known for their anti-tuberculosis [1], [2], antiproliferative [3], [4], anthelmintic [5], antibacterial [6] and antioxidant activities [7]. 4-Amino-7-chloroquinoline derivatives and its modified side-chain analogs [8], [9], [10] were representative class of antimalarial drugs. Extensive studies were made to obtain biologically active quinolines and naphthyridine analogues starting from chloro quinolines [11]. The synthesis of naphthyridines [12], benzonaphthyridines [13], and dibenzonaphthyridines [14], [15], [16] from various starting precursors were also well documented in the literature. Such naphthyridines exhibit remarkable biological activities such as CB2 selective agonists [17], anti-HIV [18], anticancer [19], [20], selective 3-phosphoinositide-dependent kinase-I inhibitors [21] and topoisomerase-I inhibitors [22]. Naphthyridines were also explored as a versatile ligand in the field of inorganic chemistry [23]. Hence, there is a continuous urge to develop new methods for the synthesis of naphthyridines. There are so many reports in the literature about the utility CuI as catalyst. For example, Buchwald explored CuI-catalysed coupling of alkylamines and aryl iodides and also the N-arylation of several nitrogen-containing substrates using specific ligands [24], [25]. Recently CuI catalysts have been received good attention for N-arylation reaction between aryl halides and amines [26], [27], which in general are high yielding reactions under mild conditions. It is also quite stable under open atmosphere, less toxic and low cost. N-arylation of aromatic heterocycles and amino acids catalysed by CuI catalyst under ligand free conditions were recently reported [28]. These features encouraged our interest in exploring the synthetic utility of CuI as a catalyst for the synthesis of benzoquinoline amine intermediates under ligand free condition. To the best of our knowledge, there are no literature reports for the synthesis of angular and linear aromatic/heteroaromatic substituted dinaphthonaphthyridines. Keeping the importance of naphthyridine compounds in mind, here in we report the synthesis of titled compounds by the reaction of 2,4-dichlorobenzo[h]quinoline via benzoquinolin-amine intermediates utilising Bernthsen reaction condition. These functionalised intermediates were prepared by simple amine-halide condensation reaction between 1-naphthylamine and 2,4-dichlorobenzo[h]quinoline using CuI as catalyst.

Experimental

General

Melting points (Mp.) were determined on Mettler FP 51 apparatus (Mettler Instruments, Switzerland) and were uncorrected. They were expressed in degree centigrade (°C). A Nicolet Avatar Model FT-IR spectrophotometer was used to record the IR spectra (4000–400 cm−1). 1H NMR and 13C NMR spectra were recorded on Bruker AV 400 (400 MHz (1H) and 100 MHz (13C)), Bruker AV 500 (500 MHz (1H) and 125 MHz (13C)) spectrometer using tetramethylsilane (TMS) as an internal reference. The chemical shifts were expressed in parts per million (ppm). Mass spectra (MS) were recorded on Auto Spec EI + Shimadzu QP 2010 PLUS GC–MS mass spectrometer. Microanalyses were performed on a Vario EL III model CHNS analyser (Vario, Germany) at the Department of Chemistry, Bharathiar University, Coimbatore – 46, India. The solvent and the reagents used (reagent grade) were purified by standard methods. Anhydrous sodium sulphate was used to dry the solution of organic extracts. Thin layer chromatography (TLC) was performed using glass plates coated with silica gel-G containing 13% calcium sulphate as binder. Ethyl acetate and petroleum ether were used as developing solvents. A chamber containing iodine vapour was used to locate the spots. Separation and purification of the crude products were carried out using chromatographic column packed with activated silica gel (60–120 mesh). In the case of mixture of solvents used for elution, the ratio of the mixture is given in brackets.

Preparation of 2,4-dichlorobenzo[h]quinoline (3)

An equimolar mixture of naphth-1-ylamine (1, 0.01 mol), malonic acid (2, 0.01 mol) and 40 mL of phosphorous oxychloride was refluxed on water bath for 8 h and the reaction was monitored by TLC. After the completion of the reaction, the reaction mixture was poured into crushed ice and neutralised with diluted solution of sodium hydroxide to give a white precipitate, which was filtered, dried and purified by silica column chromatography. The product was eluted with hexane, to obtain 3 as a white solid; Mp.: 70–72 °C; Yield: 45%; IR (KBr, cm−1) νmax: 1581 (CN); 1H NMR (400 MHz, CDCl3) (ppm) δH: 7.62 (s, 1H, C3—H), 7.74–8.08 (m, 5H, C5, C6C9—H), 9.22 (dd, 1H, J = 8.20 Hz, J = 1.20 Hz, C10—H); Anal. Calcd. for C13H7Cl2N (247): C, 62.93; H, 2.84; N, 5.65%; Found: C, 63.00; H, 2.78; N, 5.61%.

General procedure for the reaction of naphth-1-ylamine (1) with 2,4-dichlorobenzo[h] quinoline (3); preparation of 4-chloro-N-(naphth-1-yl)benzo[h]quinolin-2-amine (4) and N2,N4-di(naphth-1-yl)benzo[h]quinolin-2,4-diamine (5)

A mixture of 2,4-dichlorobenzo[h]quinoline (3, 0.010 mol), naphth-1-ylamine (1, 0.010 mol) and CuI (10 mol%) was heated in 20 mL of DMSO at 120 °C for an hour. After the completion of the reaction, water was added into the reaction mixture. The resultant precipitate was washed with water, dried and purified by column chromatography (neutral alumina). Compound 4 was eluted with petroleum ether: ethyl acetate (99:1) whereas compound 5 was eluted with ethyl acetate: methanol (95:5). Both the compounds were recrystallised using methanol.

4-Chloro-N-(naphth-1-yl)benzo[h]quinolin-2-amine (4)

White amorphous powder; Mp.: 126–128 °C; Yield: 45%; IR (KBr, cm−1) νmax: 3066 (NH), 1636 (CN); 1H NMR (500 MHz, CDCl3) (ppm) δH: 7.02 (s, 1H, C2—NH), 7.17 (s, 1H, C3—H), 7.54–7.84 (m, 8H, C8, C2′—C8′—H), 7.91 (t, 1H, J = 8.00 Hz, C9—H), 7.96 (d, 1H, J = 8.00 Hz, C6—H), 8.01 (d, 1H, J = 8.50 Hz, C7—H), 8.15 (d, 1H, J = 9.00 Hz, C5—H), 9.20 (dd, 1H, J= 8.00 Hz, J1.50 Hz, C10—H); 13C NMR (125 MHz, CDCl3) (ppm) δC: 109.17 (C3), 119.11 (C4a), 121.15 (C2′), 121.25 (C4′), 122.12 (C8′), 124.50 (C5′), 124.89 (C5), 125.95 (C7′), 126.08 (C6′), 126.50 (C3′), 126.52 (C10), 126.59 (C6), 127.77 (C9), 128.38 (C8), 128.64 (C7), 129.34 (C8a′), 130.22 (C4a′), 134.38 (C10a), 134.75 (C6a), 135.14 (C1′), 143.75 (C10b), 147.06 (C4), 155.68 (C2); MS m/z (%) 354 (M + H, 100), 356 (M + 2, 31); Anal. Calcd. for C23H15ClN2 (354): C, 77.85; H, 4.26; N, 7.89%; Found: C, 77.79; H, 4.23; N, 7.82%.

N2,N4-Di(naphth-1-yl)benzo[h]quinolin-2,4-diamine (5)

Pale brown solid; Mp.:>300 °C; Yield: 51%; IR (KBr, cm−1) νmax: 3136, 3054 (NH), 1629(CN); 1H NMR (500 MHz, DMSO-d6) (ppm) δH: 6.51 (s, 1H, C3—H), 7.01–8.19 (m, 18H, C6C9, C2′—C8′ & C2′′—, C8″—H), 8.77 (d, 1H, C5—H, J = 8.00 Hz), 9.38 (d, 1H, C10—H, J = 8.50 Hz), 10.74 (s, 1H, C4—NH), 11.45 (s, 1H, C2—NH), 14.13 (s, 1H, N1—H); 13C NMR (125 MHz, DMSO-d6) (ppm) δC: 86.26 116.36, 120.07, 121.05, 122.45, 122.82, 123.46, 125.16, 125.39, 126.30, 127.06 (2C), 127.20, 127.37, 128.27, 128.72, 128.95 (3C), 129.13, 129.32, 130.02, 132.35, 134.14, 134.34 (4C), 134.50, 134.88, 135.69, 152.88, 155.57; MS m/z (%) 462 (M + H, 100); Anal. Calcd. for C33H23N3 (461): C, 85.87; H, 5.02; N, 9.10%; Found: C, 85.94; H, 4.99; N, 9.07%.

General procedure for the synthesis of dinaphtho[b,g][1,8]naphthyridines (6–12)

4-Chloro-N-(naphth-1-yl)benzo[h]quinolin-2-amine (4, 0.002 mol) and the appropriate carboxylic acids (0.0025 mol) were added to polyphosphoric acid (6 g of P2O5 in 3 mL of H3PO4) and then heated. The reaction time, temperature maintained and various acids used for the synthesis of respective product were mentioned in Table 2. After the completion of the reaction, it was poured into ice water, neutralised with saturated sodium bicarbonate solution to remove excess of carboxylic acids and extracted with ethyl acetate. It was then purified by column chromatography using silica gel (eluted with petroleum ether: ethyl acetate (93:7) to get the compounds (6–12), which was then recrystallised using methanol.
Table 2

Synthesis and reaction conditions of compound 6–20.

CompoundsAcidProductsat (h)T (°C)
63.5230
7CH3COOH4230
83230
93230
102.5190
111160
121140
130.5rt
15CH3COOH1rt
161rt
171rt
180.5rt
190.590
200.590

rt – Room temperature.

The products were characterised by IR, NMR, MASS and elemental analysis (refer experimental section).

8-(4′-Methylphenyl)-dinaphtho[1,2-b:2′,1′-g][1,8]naphthyridin-7(16H)-one (6)

Yellow spongy mass; Mp.: 185–187 °C; Yield: 66%; IR (KBr, cm−1) νmax: 3144 (NH), 1680 (CO), 1592 (CN); 1H NMR (500 MHz, CDCl3) (ppm) δH: 2.50 (s, 3H, C4′—CH3), 7.35 (2d, 2H, C2′ & C6′—H), 7.54–8.34 (m, 12H, C2—C5, C9C13, C3′, C5′—H & C16—NH), 8.96 (d, 1H, J = 8.50 Hz, C6—H), 9.29 (dd, 1H J= 8.00 Hz, J2.00 Hz, C1—H), 9.64 (d, 1H, J = 8.50 Hz, C14—H); 13C NMR (125 MHz, CDCl3) (ppm) δC: 22.73, 119.51, 121.25, 121.91, 122.40, 123.95, 125.52, 126.73, 126.89, 127.05, 127.33, 127.64, 127.87, 127.98, 128.07, 128.58(2C), 128.92(2C), 129.62, 130.75, 131.41, 132.49, 133.56, 135.12, 136.27, 139.53, 142.31, 147.89, 155.93, 178.79; Anal. Calcd. for C31H20N2O (436): C, 85.30; H, 4.62; N, 6.42%; Found: C, 85.34; H, 4.58; N, 6.35%.

8-Methyldinaphtho[1,2-b:2′,1′-g][1,8]naphthyridin-7(16H)-one (7)

Yellow prisms; Mp.: 154–156 °C; Yield: 43%; IR (KBr, cm−1) νmax: 3295 (NH), 1640 (CO), 1554 (CN); 1H NMR (500 MHz, CDCl3) (ppm) δH: 3.07 (s, 3H, C8—CH3), 7.43–8.22 (m, 9H, C2—C5, C9C13—H), 8.51(s, 1H, C16—NH), 9.01 (d, 1H, J = 8.00 Hz, C6—H), 9.31 (dd, 1H J= 8.50 Hz, J1.50 Hz, C1—H), 9.63 (d, 1H, J = 9.00 Hz, C14—H); 13C NMR (125 MHz, CDCl3) (ppm) δC: 29.85, 119.66, 121.17, 121.85, 122.53, 124.05, 125.63, 126.69, 126.99, 127.00, 127.13, 127.72, 127.86, 127.91, 128.21, 129.76, 131.29, 132.55, 133.87, 135.34, 139.49, 142.50, 147.58, 154.90, 179.11; Anal. Calcd. for C25H16N2O (360): C, 83.31; H, 4.47; N, 7.77%; Found: C, 83.36; H, 4.54; N, 7.70%.

8-(4′-Methoxyphenyl)dinaphtho[1,2-b:2′,1′-g][1,8]naphthyridin-7(16H)-one (8)

Yellow solid; Mp.: 191–193 °C; Yield: 69%; IR (KBr, cm−1) νmax: 3166 (NH), 1626 (CO), 1567 (CN); 1H NMR (500 MHz, CDCl3) (ppm) δH: 4.05 (s, 3H, C4′—CH3), 7.26 (2d, 2H, C2′ & C6′—H), 7.38 (2d, 2H, C3′ & C5′—H), 7.40–8.09 (m, 9H, C2—C5, C9C13—H), 8.22 (s, 1H, C16—NH), 8.86 (d, 1H, J = 7.50 Hz, C6—H), 9.30 (d, 1H J = 8.00 Hz, C1—H), 9.61 (d, 1H, J = 8.50 Hz, C14—H); 13C NMR (125 MHz, DMSO-d6) (ppm) δC: 53.86, 118.96, 121.16, 121.86, 122.27, 124.15, 125.64, 126.68, 126.78, 127.15, 127.41, 127.51, 127.79, 127.90, 128.11, 128.46(2C), 129.09 (2C), 129.70, 130.64, 131.36, 132.50, 133.30, 135.30, 136.31, 139.42, 142.27, 148.90, 155.70, 178.49; Anal. Calcd. for C31H20N2O2 (452): C, 82.28; H, 4.45; N, 6.19%; Found: C, 82.34; H, 4.51; N, 6.14%.

8-(4′-Chlorophenyl)dinaphtho[1,2-b:2′,1′-g][1,8]naphthyridin-7(16H)-one (9)

Yellow solid; Mp.: 176–178 °C; Yield: 71%; IR (KBr, cm−1) νmax: 3210 (NH), 1639 (CO), 1598 (CN); 1H NMR (500 MHz, CDCl3) (ppm) δH: 7.40 (2d, 2H, C2′ & C6′—H), 7.55–8.54 (m, 12H, C2—C5, C9C13, C3′, C5′—H & C16—NH), 8.85 (d, 1H, J = 8.00 Hz, C6—H), 9.22 (dd, 1H J= 8.00 Hz, J2.00 Hz, C1—H), 9.59 (d, 1H, J = 8.50 Hz, C14—H); 13C NMR (125 MHz, DMSO-d6) (ppm) δC: 118.99, 121.09, 121.76, 122.39, 123.88, 125.67, 126.81, 126.90, 127.20, 127.29, 127.59, 127.80, 127.94, 128.21, 128.33(2C), 129.87, 130.01(2C), 130.59, 131.50, 132.38, 133.50, 135.23, 136.18, 139.61, 142.40, 147.64, 153.76, 180.06; Anal. Calcd. for C30H17ClN2O (456): C, 78.86; H, 3.75; N, 6.13%; Found: C, 78.81; H, 3.82; N, 6.07%%.

8-(4′-Nitrophenyl)dinaphtho[1,2-b:2′,1′-g][1,8]naphthyridin-7(16H)-one (10)

Dark yellow solid; Mp.: 167–169 °C; Yield: 61%; IR (KBr, cm−1) νmax: 3131 (NH), 1641 (CO), 1599 (CN); 1H NMR (500 MHz, CDCl3) (ppm) δH: 7.34–8.36 (m, 13H, C2—C5, C9C13, C2′, C6′, C3′ & C5′—H), 8.50 (s, IH, C16—NH), 8.91 (d, 1H, J = 7.50 Hz, C6—H), 9.34 (dd, 1H, J= 8.50 Hz, J1.50 Hz, C1—H), 9.65 (d, 1H, J = 9.00 Hz, C14—H); 13C NMR (125 MHz, CDCl3) (ppm) δC: 119.19, 121.36, 121.84, 122.61, 123.87, 125.73, 126.81, 126.93, 127.17, 127.41, 127.59, 127.76, 127.88, 128.11, 128.49(2C), 129.77, 130.10(2C), 130.65, 131.39, 132.33, 133.65, 134.98, 136.47, 139.62, 143.86, 148.78, 154.57, 180.11; Anal. Calcd. for C30H17N3O3 (467): C, 77.08; H, 3.67; N, 8.99%; Found: C, 77.01; H, 3.73; N, 9.04%.

8-(Pyridin-3′-yl)dinaphtho[1,2-b:2′,1′-g][1,8]naphthyridin-7(16H)-one (11)

Yellow solid; Mp.: 183–185 °C; Yield: 57%; IR (KBr, cm−1) νmax: 3243 (NH), 1655 (CO), 1590 & 1521 (CN); 1H NMR (500 MHz, CDCl3) (ppm) δH: 7.40 (t, 1H, J = 5.00 Hz C5′—H), 7.44–8.29 (m, 9H, C2—C5, C9C13—H), 8.32 (d, 1H, J = 5.50 Hz, C4′—H), 8.40 (s, 1H, C16—NH), 8.51 (d, 1H, J = 4.50 Hz, C6′—H), 8.86 (s, 1H, C2′—H), 8.93 (d, 1H, J = 8.50 Hz, C6—H), 9.27 (dd, 1H J= 9.00 Hz, J2.00 Hz, C1—H), 9.58 (d, 1H, J = 8.00 Hz, C14—H); 13C NMR (125 MHz, CDCl3) (ppm) δC: 117.55, 120.97, 121.75, 123.13, 124.67, 125.82, 125.99, 126.09, 126.77, 127.05, 127.43, 127.58, 127.81, 128.11, 128.74, 129.90, 130.19, 131.46, 132.67, 133.39, 134.70, 136.54, 138.03, 143.70, 146.75, 147.58, 149.29, 155.14, 178.88; Anal. Calcd. for C29H17N3O (423): C, 82.25; H, 4.05; N, 9.92%; Found: C, 82.30; H, 4.01; N, 9.88%.

8-(Thiophen-2′-yl)dinaphtho[1,2-b:2′,1′-g][1,8]naphthyridin-7(16H)-one (12)

Yellow solid; Mp.: 177–179 °C; Yield: 41%; IR (KBr, cm−1) νmax: 3209 (NH), 1645 (CO), 1592 & 1528 (CN); 1H NMR (500 MHz, CDCl3) (ppm) δH: 7.19 (t, 1H, J = 5.00 Hz C4′—H), 7.31–8.18 (m, 11H, C2—C5, C9C13, C3′ & C5′—H), 8.38(s, 1H, C16—NH), 9.03 (d, 1H, J = 7.50 Hz, C6—H), 9.28 (dd, 1H, J= 8.00 Hz, J2.50 Hz, C1—H), 9.52 (d, 1H, J = 8.50 Hz, C14—H); Anal. Calcd. for C28H16N2OS (428): C, 78.48; H, 3.76; N, 6.54; S, 7.48%; Found: C, 78.53; H, 3.80; N, 6.49; S, 7.51%.

General procedure for the synthesis of dinaphtho[b,h][1,6]naphthyridines (13–20)

A mixture of N-di(naphth-1-yl)benzo[h]quinoline-2,4-diamine (5, 0.002 mol) and appropriate carboxylic acids (0.0025 mol) were added to polyphosphoric acid (6 g of P2O5 in 3 mL of H3PO4). The reaction time, temperature maintained and various acids used for synthesis of the respective product were mentioned in Table 2. The reaction was monitored by TLC. After the completion of the reaction, it was poured into ice water, neutralised with saturated solution of sodium bicarbonate to remove excess of carboxylic acids, extracted with ethyl acetate, purified by column chromatography using silica gel and product was eluted with petroleum ether:ethyl acetate (97:3) mixture to get (13–20) which was recrystallised using methanol.

N-(Naphth-1″-yl)-7-(4′-methylphenyl)-dinaphtho[1,2-b:1′,2′-h][1,6]naphthyridin-6-amine (13)

Orange prisms; Mp.: 262–264 °C; Yield: 75%; IR (KBr, cm−1) νmax: 3048 (NH), 1655, 1601 (CN); 1H NMR (500 MHz, CDCl3) (ppm) δH: 2.48 (s, 3H, C4′—CH3), 7.25–8.32 (m, 20H, C2, C3, C8, C9, C10, C11, C12, C16, C2′, C3′, C5′, C6′, C2″—C8″ and C6—NH), 8.87 (d, 1H, C1—H, J = 8.00 Hz), 8.95 (d, 1H, C16—H, J = 7.50 Hz), 9.27 (d, 1H, C4—H J = 8.00 Hz), 9.51 (d, 1H, C15—H, J = 8.00 Hz), 9.87 (d, 1H, C13—H, J = 7.50 Hz); 13C NMR (125 MHz, CDCl3) (ppm) δC: 22.56 (C4′—CH3), 114.27, 119.33, 120.57, 121.07, 121.86, 122.11, 122.96, 123.41, 124.25, 125.18, 126.01, 126.59, 126.68, 126.92, 127.22, 127.34, 127.41, 127.50, 127.63, 127.77, 127.89, 128.35 (2C), 128.90 (2C), 129.06, 129.42, 130.24, 130.86, 131.57, 132.69, 133.48, 134.03, 134.85, 136.13, 140.72, 144.55, 147.71, 149.90, 158.07; MS (EI) m/z (%) 561 (M+, 75); Anal. Calcd. for C41H27N3 (561): C, 87.67; H, 4.85; N, 7.48%; Found: C, 87.61; H, 4.90; N, 7.51%.

7-Methyl-N-(naphth-1″-yl)dinaphtho[1,2-b:1′,2′-h][1,6]naphthyridin-6-amine (15)

Orange solid; Mp.: 241–243 °C; Yield: 57%; IR (KBr, cm−1) νmax: 3098 (NH), 1635, 1611 (CN); 1H NMR (500 MHz, CDCl3) (ppm) δH: 3.26 (s, 3H, C7—CH3), 7.39–8.29 (m, 15H, C2, C3, C8, C9, C10, C11, C12, C2″—C8″ and C6—NH), 8.76 (d, 1H, C1—H, J = 8.00 Hz), 8.95 (d, 1H, C16—H, J = 7.50 Hz), 9.30 (d, 1H, C4—H J = 8.00 Hz), 9.55 (d, 1H, C15—H, J = 8.00 Hz), 9.85 (d, 1H, C13—H, J = 7.50 Hz); 13C NMR (125 MHz, CDCl3) (ppm) δC: 26.6 (C7—CH3), 113.89, 118.61, 120.09, 121.11, 121.72, 122.26, 122.73, 123.50, 124.39, 125.24, 126.11, 126.47, 126.59, 126.89, 127.14, 127.26, 127.31, 127.60, 127.71, 127.82, 127.99, 129.00, 129.37, 130.51, 131.66, 132.73, 133.53, 134.16, 135.24, 141.03, 144.62, 147.31, 148.76, 157.12; MS (EI) m/z (%) 485 (M+, 79); Anal. Calcd. for C35H23N3 (485): C, 86.57; H, 4.77; N, 8.65%; Found: C, 86.61; H, 4.84; N, 8.59%.

7-(4′-Methoxyphenyl)-N-(naphth-1″-yl)dinaphtho[1,2-b:1′,2′-h][1,6]naphthyridin-6-amine (16)

Orange prisms; Mp.: 271–273 °C; Yield: 61%; IR (KBr, cm−1) νmax: 3123 (NH), 1617, 1581(CN); 1H NMR (500 MHz, CDCl3) (ppm) δH: 3.81 (s, 3H, C4′—OCH3), 7.27–8.23 (m, 19H, C2, C3, C8, C9, C10, C11, C12, C2′, C3′, C5′, C6′, C2″—C8″ and C6—NH), 8.85 (d, 1H, C1—H, J = 8.50 Hz), 8.98 (d, 1H, C16—H, J = 8.00 Hz), 9.33 (d, 1H, C4—H J = 8.00 Hz), 9.49 (d, 1H, C15—H, J = 8.50 Hz), 9.90 (d, 1H, C13—H, J = 8.00 Hz); 13C NMR (125 MHz, CDCl3) (ppm) δC: 55.99 (C4′—OCH3), 113.94, 119.45, 120.66, 121.12, 121.70, 122.02, 122.76, 123.53, 124.44, 125.26, 126.18, 126.47, 126.71, 126.88, 127.30, 127.42, 127.53, 127.64, 127.76, 127.85, 127.91, 128.45 (2C), 128.86 (2C), 129.19, 129.50, 130.42, 130.77, 131.65, 132.52, 133.64, 134.41, 134.67, 135.28, 141.25, 143.48, 146.17, 149.56, 157.71; MS (EI) m/z (%) 577 (M+, 91); Anal. Calcd. for C41H27N3O (577): C, 85.25; H, 4.71; N, 7.27%; Found: C, 85.31; H, 4.77; N, 7.20%.

7-(4′-Chlorophenyl)-N-(naphth-1″-yl)dinaphtho[1,2-b:1′,2′-h][1,6]naphthyridin-6-amine (17)

Orange prisms; Mp.: 255–257 °C; Yield: 69%; IR (KBr, cm−1) νmax: 3134(NH), 1609, 1590(CN); 1H NMR (500 MHz, CDCl3) (ppm) δH: 7.30–8.13 (m, 19H, C2, C3, C8, C9, C10, C11, C12, C2′, C3′, C5′, C6′, C2″—C8″ and C6—NH), 8.71 (d, 1H, C1—H, J = 7.50 Hz), 8.96 (d, 1H, C16—H, J = 8.50 Hz), 9.38 (d, 1H, C4—H J = 9.00 Hz), 9.59 (d, 1H, C15—H, J = 8.00 Hz), 9.87 (d, 1H, C13—H, J = 8.50 Hz); 13C NMR (125 MHz, CDCl3) (ppm) δC: 114.32, 118.90, 120.46, 121.00, 121.51, 122.31, 122.78, 123.55, 124.39, 125.30, 126.14, 126.60, 126.76, 126.81, 127.19, 127.28, 127.37, 127.47, 127.56, 127.66, 127.75, 128.40 (2C), 128.87 (2C), 129.19, 129.37, 130.46, 130.68, 131.94, 132.75, 133.71, 134.42, 134.73, 135.28, 140.44, 145.16, 148.54, 149.70, 158.24; MS (EI) m/z (%) 581 (M+, 81), 583 (M+2, 31); Anal. Calcd. For C40H24ClN3 (581): C, 82.53; H, 4.16; N, 7.22%; Found: C, 82.59; H, 4.09; N, 7.160%.

N-(Naphth-1″-yl)-7-(4′-nitrophenyl)dinaphtho[1,2-b:1′,2′-h][1,6]naphthyridin-6-amine (18)

Pale orange prisms; Mp.: 251–253 °C; Yield: 57%; IR (KBr, cm−1) νmax: 3201, 1644, 1571; 1H NMR (500 MHz, CDCl3) (ppm) δH: 7.32–8.27 (m, 19H, C2, C3, C8, C9, C10, C11, C12, C2′, C3′, C5′, C6′, C2″—C8″ and C6—NH), 8.84 (d, 1H, C1—H, J = 8.00 Hz), 8.96 (d, 1H, C16—H, J = 9.00 Hz), 9.31 (d, 1H, C4—H J = 8.00 Hz), 9.58 (d, 1H, C15—H, J = 8.50 Hz), 9.91 (d, 1H, C13—H, J = 8.00 Hz); 13C NMR (125 MHz, CDCl3) (ppm) δC: 113.94, 118.80, 120.76, 121.33, 121.90, 122.27, 122.81, 123.65, 124.84, 125.37, 126.25, 126.48, 126.70, 126.95, 127.01, 127.26, 127.39, 127.47, 127.56, 127.64, 127.99, 128.51 (2C), 128.99 (2C), 129.13, 129.59, 130.42, 130.68, 131.77, 132.36, 133.84, 134.22, 134.49, 135.30, 140.57, 143.67, 146.85, 148.70, 159.19; MS (EI) m/z (%) 592 (M+, 90); Anal. Calcd. for C40H24N4O2 (592): C, 81.07; H, 4.08; N, 9.45%; Found: C, 81.14; H, 4.03; N, 9.51%.

N-(Naphth-1″-yl)-7-(pyridin-3′-yl)dinaphtho[1,2-b:1′,2′-h][1,6]naphthyridin-6-amine (19)

Orange solid; Mp.: 233–235 °C; Yield: 41%; IR (KBr, cm−1) νmax: 3086 (NH), 1625, 1603 (CN); 1H NMR (500 MHz, CDCl3) (ppm) δH: 7.39–8.29 (m, 16H, C2, C3, C8, C9, C10, C11, C12, C5′, C2″—C8″ and C6—NH), 8.41 (d, 1H, C4′—H, J = 4.50 Hz), 8.59 (d, 1H, C6′—H, J = 5.50 Hz), 8.77 (s, 1H, C2′—H), 8.81 (d, 1H, C1—H, J = 8.50 Hz), 8.99 (d, 1H, C16—H, J = 7.50 Hz), 9.27 (d, 1H, C4—H J = 8.50 Hz), 9.49 (d, 1H, C15—H, J = 9.00 Hz), 9.78 (d, 1H, C13—H, J = 7.50 Hz); 13C NMR (125 MHz, CDCl3) (ppm) δC: 114.65, 117.43, 129.99, 120.82, 121.09, 122.04, 122.59, 123.00, 124.71, 125.69, 126.26, 126.49, 126.60, 126.98, 127.09, 127.31, 127.42, 127.56, 127.76, 127.89, 127.95, 128.34, 129.13, 129.59, 130.66, 131.73, 132.65, 133.38, 133.72, 134.27, 135.54, 136.09, 141.36, 144.71, 145.54, 147.37, 148.82, 149.47, 156.90; MS (EI) m/z (%) 548 (M+, 100); Anal. Calcd. for C39H24N4 (548): C, 85.38; H, 4.41; N, 10.21%; Found: C, 85.42; H, 4.40; N, 10.18%.

N-(Naphth-1″-yl)-7-(thiophen-2′-yl)dinaphtho[1,2-b:1′,2′-h][1,6]naphthyridin-6-amine (20)

Orange solid; Mp.: 228–230 °C; Yield: 33%; IR (KBr, cm−1) νmax: 3077 (NH), 1643, 1621 (CN); 1H NMR (500 MHz, CDCl3) (ppm) δH: 7.22 (t, 1H, C4′—H, J = 5.50 Hz), 7.32–8.34 (m, 18H, C2, C3, C8, C9, C10, C11, C12, C3′, C5′, C2″—C8″ and C6—NH), 8.46 (d, 1H, C4′—H, J = 4.50 Hz), 8.66 (d, 1H, C6′—H, J = 5.50 Hz), 8.80 (s, 1H, C2′—H), 8.92 (d, 1H, C1—H, J = 8.50 Hz), 9.17 (d, 1H, C16—H, J = 7.50 Hz), 9.31 (d, 1H, C4—H J = 8.50 Hz), 9.54 (d, 1H, C15—H, J = 9.00 Hz), 9.74 (d, 1H, C13—H, J = 7.50 Hz); MS (EI) m/z (%) 553 (M+, 100); Anal. Calcd. for C38H23N3S (553): C, 82.43; H, 4.19; N, 7.59; S, 5.79%; Found: C, 82.38; H, 4.21; N, 7.60; S, 5.81%.

Results and discussion

Synthesis of dinaphtho[b,g][1,8]naphthyridines

The required precursor for the synthesis of substituted angular and linear dinaphthonaphthyridines, 2,4-dichlorobenzo[h]quinoline (3) was obtained from naphth-1-ylamine 1 and malonic acid (2) under reflux in POCl3 for 8 h as depicted in Scheme 1.
Scheme 1

Synthesis of 2,4-dichlorobenzo[h]quinoline (3).

Synthesis of 2,4-dichlorobenzo[h]quinoline (3). Compound 3 was then reacted with naphth-1-ylamine 1 in the presence of CuI catalyst, afforded 4 and 5. The reaction conditions and the yields of the two compounds obtained were depicted in Table 1. In the absence of catalyst the reaction in methanol gave 31% of compound 4 and 28% of compound 5 in 8 h (entry 1 in Table 1), whereas by using 10 mol% of CuI as catalyst reduces the reaction time from 8 h to 2 h and increased the yield of the products marginally (entry 2 in Table 1). When the solvent was changed from methanol to ethanol, we obtained the compounds 4 & 5 in 40% and 38% respectively in 2 h using 10 mol% of CuI (entry 4 in Table 1). To our surprise, when the reaction was performed in DMSO as solvent (using 10 mol% of CuI) within 0.5 h we obtained 57% and 31% of compounds 4 & 5 (entry 6 in Table 1). Interestingly, when the reaction was allowed for another half an hour (entry 7 in Table 1) product 5 was obtained as a major product (51%) along with 45% yield of compound 4. It is noteworthy to mention here that, reaction in DMSO in the absence of catalyst, (entry 8 in Table 1) even after 8 h resulted in 30% and 27% of the compounds 4 and 5. In the presence of catalyst the reaction time came down from 8 h to 0.5 h with the combined (4 + 5) yield of 96%. But in the absence of catalyst, the combined yield of 4 & 5 was 57%. Reduction of time and substantial increase in yield clearly indicate the effect of CuI catalyst in the reaction.
Table 1

The reaction conditions and the yields of the two compounds 4 and 5.

EntryCatalystaSolventT (°C)t (h)Yield (%) of the products
45
1MeOHReflux83128
2CuIMeOHReflux23732
3EthanolReflux83129
4CuIEthanolReflux24038
5CuIDMFReflux8NRNR
6CuIDMSO1200.55731
7CuIDMSO12014551
8DMSO12083027

10 mol% of catalyst.

The reaction conditions and the yields of the two compounds 4 and 5. 10 mol% of catalyst. Synthesis and reaction conditions of compound 6–20. rt – Room temperature. The products were characterised by IR, NMR, MASS and elemental analysis (refer experimental section). It is documented that in SNAr, the reaction rate gets accelerated by activating the amine through hydrogen bonding when the reaction was performed in polar aprotic solvent like DMSO [29], [30]. Hence it is anticipated that the second step (I to II in Scheme 3) was accelerated in the presence of DMSO and hence the possible explanation for the increased yield when the reaction was performed in DMSO/CuI (entry 7 in Table 1). The present finding showed that the combination of DMSO and CuI turns out to be the best among the combination screened.
Scheme 3

Mechanism for the formation of compound (4).

IR spectrum of the first eluted product showed stretching vibrations at 3066 cm−1 and 1636 cm−1 due to NH and CN groups. In its 1H NMR spectrum, C4—NH appeared as a broad singlet at δ 7.02, C3—H appeared as a singlet at δ 7.17 and all the aromatic protons appeared between the region δ 7.54 and 9.20. Its 13C NMR spectrum showed the presence of twenty-three carbons and its mass spectrum showed the molecular ion peak at m/z 354. On the basis of the reactivity of chlorine atom in the 2 and 4 positions of the 2,4-dichloroquinoline [31], [32], the first compound was assigned as 2-substituted product namely, 4-chloro-N-(naphth-1-yl)benzo[h]quinolin-2-amine (4). The second product showed stretching frequencies at 3136 cm−1, 3054 cm−1 and 1629 cm−1 in the IR spectrum due to two NH and CN functional groups. In its 1H NMR spectrum C3—H appeared as a singlet at δ 6.51, all the aromatic protons appeared between the region δ 7.01 and 9.38. Three broad singlets appeared at δ 10.74, 11.45 and 14.13 were assigned for C4—NH, C2—NH and N1—H, respectively. Its 13C NMR spectrum showed the presence of 33 carbons. All the aforesaid data attest the obtained product as 2,4-disubstituted product, namely, N2,N4-di(naphth-1-yl)benzo[h]quinoline-2,4-diamine (5) which was found to be in resonance with the two imino forms on the basis of its IR and 1H NMR spectra (Scheme 2).
Scheme 2

Synthesis of benzoquinolin-amines (4) and (5).

Synthesis of benzoquinolin-amines (4) and (5). Mechanism for the formation of compound (4). The proposed plausible mechanism for the formation of compound 4 is as follows. The first step involves the oxidative addition of compound 3 with CuI to form the intermediate I. Then the elimination of H and Cl elements between the intermediate I and compound 1 leads to the formation of intermediate II. This further undergoes reductive elimination to give compound 4 and regenerated the catalyst. Compound 4 undergoes a similar catalytic cycle to afford compound 5 (Scheme 3). In order to get the target linear dinaphthonaphthyridine, 4-chloro-N-(naphth-1-yl)benzo[h] quinolin-2-amine (4) was reacted with p-toluic acid in the presence of poly phosphoric acid at 230 °C which afforded a single product. The IR spectrum showed stretching frequencies at 3144 cm−1, 1680 cm−1 and 1592 cm−1 revealed the presence of NH, CO and CN functional groups respectively. In its 1H NMR spectrum a singlet at δ 2.50 was due to the presence of C4′—CH3 proton. Rest of the aromatic protons resonated in the region between δ 7.35 and 9.64 including C16—NH. Its 13C NMR spectrum showed the peak at δ 178.79 due to the presence of CO group. The molecular formula of the product was found to be C31H20N2O calculated from elemental analysis. From the aforementioned spectral and analytical information, the structure of compound has been assigned as 8-(4′-methylphenyl)-dinaphtho[1,2-b:2′,1′-g][1,8]naphthyridin-7(16H)-one (6) (Scheme 4).
Scheme 4

Synthesis of dinaphtho[b,g][1,8]naphthyridine (6).

Synthesis of dinaphtho[b,g][1,8]naphthyridine (6). To explore the generality of the reaction, we have also tried the same reaction with other carboxylic acids like acetic acid, p-methoxy benzoic acid, p-chloro benzoic acid, p-nitro benzoic acid, pyridine-3-carboxylic acid and thiophen-2-carboxylic acid to get the corresponding linear 8-substituted dinaphtho[1,2-b:2′,1′-g][1,8]naphthyridin-7(16H)-one (7–12) Table 2. The structures of all compounds were confirmed by elemental and spectral analysis (refer experimental section and supporting data).

Synthesis of dinaphtho[b,h][1,6]naphthyridines

Next, in order to construct angular naphthyridines N2,N4-di(naphth-1-yl) benzo[h]quinoline-2,4-diamine (5) was reacted with p-toluic acid in the presence of poly phosphoric acid as catalyst at room temperature (stirring for half an hour). The IR spectrum showed stretching frequencies at 3048 cm−1, 1655 cm−1 and 1601 cm−1 which were due to the presence of NH and two CN functional groups respectively. In its 1H NMR spectrum, methyl protons appeared as a singlet at δ 2.48 for C4′—CH3. All the aromatic protons appeared between the region δ 7.25 and 8.95 except for C4—H, C15—H and C13—H which appeared as three doublets at δ 9.27 (J = 8.00 Hz, J = 1.50 Hz), 9.51 (J = 8.00 Hz) and 9.87 (J = 7.50 Hz) respectively. The 13C NMR spectrum showed the presence of 41 carbons. All the spectral data revealed the formation of the compound 13. Here the chance of getting the linear naphthyridine 14 has not been observed and the only formed product was assigned as the thermodynamically more stable angular isomer namely, N-(naphth-1″-yl)-7-(4′-methylphenyl)-dinaphtho[1,2-b:1′,2′-h][1,6]naphthyridin-6-amine 13, on the basis of its higher melting point and literature data [33], [34] (Scheme 5).
Scheme 5

Synthesis of dinaphtho[b,h][1,6]naphthyridine (13).

Synthesis of dinaphtho[b,h][1,6]naphthyridine (13). Encouraged by these results, this procedure was then further evaluated for its scope and general applicability. A similar set of reaction was extended to 5 with acetic acid, p-methoxy benzoic acid, p-chloro benzoic acid, p-nitro benzoic, pyridine-3-carboxylic acid and thiophen-2-carboxylic acid in the presence of polyphosphoric acid to afford the respective 7-substituted dinaphtho[1,2-b:1′,2′-h][1,6]naphthyridin-6-amine (15–20) as a single compound (Table 2). Very interestingly electron withdrawing group substituted benzoic acid undergoes cyclisation in shorter reaction time when compared to electron donating group substituted benzoic acid. The structures of all compounds were confirmed by elemental and spectral analysis (refer experimental section and supporting data).

Conclusions

A useful method for the synthesis of intermediates 4 and 5 using 10 mol% of CuI catalyst was developed. Both the intermediates undergo facile cyclisation under poly phosphoric acid condition with aliphatic and various aromatic/heteroaromatic carboxylic acids afforded angular and linear dinaphthonaphthyridines. This method has the potential to create new libraries of substituted dinaphthonaphthyridines which may find applications in medicinal chemistry.

Conflict of interest

The authors have declared no conflict of interest.

Compliance with Ethics Requirements

This article does not contain any studies with human or animal subjects.
  21 in total

1.  A general and efficient copper catalyst for the amidation of aryl halides and the N-arylation of nitrogen heterocycles.

Authors:  A Klapars; J C Antilla; X Huang; S L Buchwald
Journal:  J Am Chem Soc       Date:  2001-08-08       Impact factor: 15.419

2.  Alumina-supported synthesis of antibacterial quinolines using microwaves.

Authors:  M Kidwai; K R Bhushan; P Sapra; R K Saxena; R Gupta
Journal:  Bioorg Med Chem       Date:  2000-01       Impact factor: 3.641

3.  Synthesis of N1-arylidene-N2-quinolyl- and N2-acrydinylhydrazones as potent antimalarial agents active against CQ-resistant P. falciparum strains.

Authors:  Sandra Gemma; Gagan Kukreja; Caterina Fattorusso; Marco Persico; Maria P Romano; Maria Altarelli; Luisa Savini; Giuseppe Campiani; Ernesto Fattorusso; Nicoletta Basilico; Donatella Taramelli; Vanessa Yardley; Stefania Butini
Journal:  Bioorg Med Chem Lett       Date:  2006-08-04       Impact factor: 2.823

4.  Synthetic antimalarials; some arylamino-aminoalkyl-aminoquinoline derivatives.

Authors:  F H S CURD; C G RAISON; F L ROSE
Journal:  J Chem Soc       Date:  1947-07

5.  In vitro antimalarial activity, β-haematin inhibition and structure-activity relationships in a series of quinoline triazoles.

Authors:  Mukesh C Joshi; Kathryn J Wicht; Dale Taylor; Roger Hunter; Peter J Smith; Timothy J Egan
Journal:  Eur J Med Chem       Date:  2013-09-12       Impact factor: 6.514

6.  Synthesis, antibacterial and antioxidant activities of new 1-alkyl-4-(1-alkyl-4-oxo-1,4-dihydroquinolin-2-yl)pyridinium bromides.

Authors:  Nuran Kahriman; Büşra Yaylı; Ayça Aktaş; Zeynep Iskefiyeli; Fatih Şaban Beriş; Nurettin Yaylı
Journal:  Eur J Med Chem       Date:  2013-09-12       Impact factor: 6.514

7.  cis-Dichloroplatinum(II) complexes tethered to dibenzo[c,h][1,6]naphthyridin-6-ones: synthesis and cytotoxicity in human cancer cell lines in vitro.

Authors:  Nicolas Desbois; David Pertuit; Johnny Moretto; Claire Cachia; Bruno Chauffert; Florence Bouyer
Journal:  Eur J Med Chem       Date:  2013-09-26       Impact factor: 6.514

8.  Design, synthesis and biological evaluation of novel triazole, urea and thiourea derivatives of quinoline against Mycobacterium tuberculosis.

Authors:  Ram Shankar Upadhayaya; Girish M Kulkarni; Nageswara Rao Vasireddy; Jaya Kishore Vandavasi; Shailesh S Dixit; Vivek Sharma; Jyoti Chattopadhyaya
Journal:  Bioorg Med Chem       Date:  2009-05-05       Impact factor: 3.641

9.  Discovery of dibenzo[c,f][2,7]naphthyridines as potent and selective 3-phosphoinositide-dependent kinase-1 inhibitors.

Authors:  Ariamala Gopalsamy; Mengxiao Shi; Diane H Boschelli; Robert Williamson; Andrea Olland; Yongbo Hu; Girija Krishnamurthy; Xin Han; Kim Arndt; Bing Guo
Journal:  J Med Chem       Date:  2007-10-17       Impact factor: 7.446

10.  New 1,8-naphthyridine and quinoline derivatives as CB2 selective agonists.

Authors:  Clementina Manera; Maria Grazia Cascio; Veronica Benetti; Marco Allarà; Tiziano Tuccinardi; Adriano Martinelli; Giuseppe Saccomanni; Elisa Vivoli; Carla Ghelardini; Vincenzo Di Marzo; Pier Luigi Ferrarini
Journal:  Bioorg Med Chem Lett       Date:  2007-10-01       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.